Barclays’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-5,400
Closed -$661K – 4914
2021
Q4
$661K Buy
+5,400
New +$600K ﹤0.01% 3060
2019
Q2
– Sell
-500
Closed -$24K – 6912
2019
Q1
$24K Buy
+500
New +$27.7K ﹤0.01% 6276
2018
Q4
– Sell
-293,700
Closed -$16.1M – 6902
2018
Q3
$16.1M Buy
293,700
+293,600
+293,600% +$16.8M 0.01% 976
2018
Q2
$6K Sell
100
-100
-50% -$5.97K ﹤0.01% 6660
2018
Q1
$11K Sell
200
-800
-80% -$43.5K ﹤0.01% 6623
2017
Q4
$49K Hold
1,000
– – ﹤0.01% 5767
2017
Q3
$46K Buy
1,000
+900
+900% +$34.4K ﹤0.01% 5384
2017
Q2
$4K Hold
100
– – ﹤0.01% 6264
2017
Q1
$4K Hold
100
– – ﹤0.01% 6314
2016
Q4
$4K Buy
+100
New +$3.42K ﹤0.01% 6164

Other funds holding AMN

Barclays's AMN Position: Q3 2026 in Review

Barclays increased its AMN Healthcare (AMN) stake by 2,457% in Q3 2026, buying an estimated $5.46M and bringing the position to 167,060 shares worth $5.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1932.

Barclays first reported a position in AMN in Q2 2013 and has held it in 54 quarters since. The position peaked at $13.3M in Q2 2025. 308 funds tracked by Wall St. Rank hold AMN as of Q3 2026.

  • Barclays held 167,060 shares of AMN Healthcare worth $5.99M as of Q3 2026.
  • Barclays bought 160,527 AMN Healthcare shares in Q3 2026, an estimated $5.46M.
  • AMN Healthcare made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1932 holding.
  • Barclays first reported a position in AMN Healthcare in Q2 2013 and has held it in 54 quarters since.
  • Barclays's AMN Healthcare position peaked at $13.3M in Q2 2025.
  • 308 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.